AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 60 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 11.10 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $317,000 | -43.2% | 285,351 | -6.4% | 0.00% | – |
| Q2 2014 | $558,000 | +17.5% | 304,986 | -4.0% | 0.00% | – |
| Q1 2014 | $475,000 | -33.8% | 317,677 | -18.5% | 0.00% | -100.0% |
| Q4 2013 | $717,000 | -14.7% | 389,637 | -4.1% | 0.00% | 0.0% |
| Q3 2013 | $841,000 | +6.9% | 406,217 | +29.0% | 0.00% | 0.0% |
| Q2 2013 | $787,000 | – | 314,876 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |